Osaic Holdings’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.2K | Buy |
40,291
+15,216
| +61% | +$27.2K | ﹤0.01% | 5163 |
|
|
2025
Q4 | $46.9K | Buy |
25,075
+4,877
| +24% | +$9.37K | ﹤0.01% | 5283 |
|
|
2025
Q3 | $25.7K | Sell |
20,198
-16,575
| -45% | -$22.4K | ﹤0.01% | 5769 |
|
|
2025
Q2 | $45.6K | Sell |
36,773
-664
| -2% | -$767 | ﹤0.01% | 5122 |
|
|
2025
Q1 | $44.2K | Sell |
37,437
-683
| -2% | -$1.05K | ﹤0.01% | 4812 |
|
|
2024
Q4 | $69.7K | Sell |
38,120
-49,253
| -56% | -$96.1K | ﹤0.01% | 4447 |
|
|
2024
Q3 | $149K | Buy |
87,373
+1,126
| +1% | +$1.85K | ﹤0.01% | 3900 |
|
|
2024
Q2 | $118K | Sell |
86,247
-9,476
| -10% | -$19.1K | ﹤0.01% | 4000 |
|
|
2024
Q1 | $359K | Buy |
95,723
+34,971
| +58% | +$205K | ﹤0.01% | 3209 |
|
|
2023
Q4 | $596K | Buy |
60,752
+22,011
| +57% | +$180K | ﹤0.01% | 3008 |
|
|
2023
Q3 | $323K | Sell |
38,741
-1,834
| -5% | -$21K | ﹤0.01% | 3614 |
|
|
2023
Q2 | $540K | Sell |
40,575
-1,148
| -3% | -$14K | ﹤0.01% | 3082 |
|
|
2023
Q1 | $483K | Buy |
41,723
+4,745
| +13% | +$47.2K | ﹤0.01% | 3122 |
|
|
2022
Q4 | $303K | Buy |
36,978
+24,648
| +200% | +$212K | ﹤0.01% | 3507 |
|
|
2022
Q3 | $72K | Buy |
12,330
+690
| +6% | +$3.96K | ﹤0.01% | 4633 |
|
|
2022
Q2 | $52K | Sell |
11,640
-3,212
| -22% | -$19.5K | ﹤0.01% | 4931 |
|
|
2022
Q1 | $1.85M | Buy |
14,852
+330
| +2% | +$3.8K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $299K | Buy |
14,522
+6,050
| +71% | +$146K | ﹤0.01% | 3566 |
|
|
2021
Q3 | $216K | Buy |
8,472
+400
| +5% | +$11.9K | ﹤0.01% | 3830 |
|
|
2021
Q2 | $284K | Buy |
8,072
+329
| +4% | +$9.57K | ﹤0.01% | 3570 |
|
|
2021
Q1 | $258K | Buy |
7,743
+3,028
| +64% | +$106K | ﹤0.01% | 3521 |
|
|
2020
Q4 | $123K | Buy |
+4,715
| New | +$80.1K | ﹤0.01% | 3901 |
|
Other funds holding PACB
AIM
VCM
NAMA
